Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-26 @ 4:08 AM
Study NCT ID:
NCT04695327
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2021-01-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy
Sponsor:
TILT Biotherapeutics Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-04
First Submit QC Date:
None
Study First Post Date:
2021-01-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-08
Last Update Post Date:
2024-03-12
Last Update Post Date Type:
ACTUAL